Remote Clinical Project Manager - Inflammation (Phase 2b)

Syneos Health; Maryland; On-site; USD 140,000 - 170,000; Full time

Benefits offered by this job

Company car

Health benefits

401k match

Stock Purchase Plan

Bonuses

PTO & Sick time

Job summary

Syneos Health is seeking an Experienced Clinical Project Manager II for an inflammation program, focused on sponsor-dedicated remote work within the US. You will own end-to-end study execution, align cross-functional teams, and drive operational leadership in a fast-paced environment.

The role emphasizes independent study progress, vendor oversight, and strong collaboration across Clinical Operations and external partners.

Qualifications

• 3+ years of clinical project management experience in clinical research.
• Experience running clinical trials from start-up through closeout.
• Experience supporting complex Phase 2b studies in inflammation.

Responsibilities

• Lead end-to-end execution of a Phase 2b inflammation study.
• Manage day-to-day study operations with minimal oversight.
• Own timelines, deliverables, risks, and issue resolution across workstreams.
• Maintain operational awareness across all trial aspects and adapt to shifting priorities.
• Partner cross-functionally to identify risks and implement timely solutions.
• Oversee vendor management and CRO performance to ensure timelines and quality.

Skills

Clinical project management

Trial execution

CRO/vendor management

Cross-functional leadership

Operational execution

Matrixed environment

Risk management

Study budgeting

Tools

Microsoft Word

Microsoft Excel

PowerPoint

Job description

Syneos Health is seeking an Experienced Clinical Project Manager II for an inflammation program, focused on sponsor-dedicated remote work within the US. You will own end-to-end study execution, align cross-functional teams, and drive operational leadership in a fast-paced environment.

The role emphasizes independent study progress, vendor oversight, and strong collaboration across Clinical Operations and external partners.